Brief Report: Relationship Among Viral Load Outcomes in HIV Treatment Interruption Trials. - Wikidata - awgldk - TriplyDB

Brief Report: Relationship Among Viral Load Outcomes in HIV Treatment Interruption Trials.

Brief Report: Relationship Among Viral Load Outcomes in HIV Treatment Interruption Trials.

http://www.wikidata.org/entity/Q37014116

about

New challenges in therapeutic vaccines against HIV infection.Autologous Stem Cell Transplantation Disrupts Adaptive Immune Responses during Rebound Simian/Human Immunodeficiency Virus Viremia.Highlights from the Conference on Retroviruses and Opportunistic Infections 2016: 22-25 February 2016, Boston, Massachusetts, USA.Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B.

P2860

Q38692205-8C74656F-B9C8-40DC-8418-0183E74D1E5C Q38839394-AD12AB96-230D-4795-B16E-72EF93B47AB0 Q40591692-379E2640-F05E-4C0F-89DA-84F2E82E0726 Q41929341-34BE24C7-B944-41D4-8A93-6A4348885D7C

P2860

Brief Report: Relationship Among Viral Load Outcomes in HIV Treatment Interruption Trials.

http://www.wikidata.org/entity/Q37014116

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 February 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Brief Report: Relationship Amo ...... Treatment Interruption Trials.

@en

Brief Report: Relationship Amo ...... Treatment Interruption Trials.

@nl

type

label

Brief Report: Relationship Amo ...... Treatment Interruption Trials.

@en

Brief Report: Relationship Amo ...... Treatment Interruption Trials.

@nl

prefLabel

Brief Report: Relationship Amo ...... Treatment Interruption Trials.

@en

Brief Report: Relationship Amo ...... Treatment Interruption Trials.

@nl

P1433

Q37014116-6F7B5DDF-0EF3-4714-8429-72A74E5B28D9

P1476

Q37014116-7E9F3F4D-CF82-41D7-8B5C-4C27F6B286ED

P2093

Q37014116-10EE3941-D366-41E7-A8E8-C16880BAF405

Q37014116-2096FE59-1637-4B1D-BE99-2A9EFB8EB2B3

Q37014116-57B0F1ED-8DD4-4C80-A12E-1C3EE6D121D5

Q37014116-57D74BB4-8CEE-4205-94E3-D8AE7CEA0869

Q37014116-764885BC-06BF-4FEC-856A-36077EAA890A

Q37014116-8226D08F-B7EA-4C21-B82E-CD707BEF0581

Q37014116-B0ECC780-66CE-4C37-A114-FD5CEE3A0FF9

Q37014116-DBC38A8C-4348-4534-BEB8-1E3C14D7A79D

P2860

Q37014116-07D4AA8F-C090-4B10-8470-7BB7024C8938

Q37014116-1EEDB954-0EEA-4229-B9C3-F492FCFB8623

Q37014116-233E49CB-A6C2-46E6-8A74-5CE4CE132674

Q37014116-277F5941-23EC-485C-AF60-2879CAAA9A24

Q37014116-2B8ED69E-BA42-49BF-A83F-2393DCE10CAA

Q37014116-4B4A6337-D20C-4E32-A01C-47B20914BD7D

Q37014116-52EC88A2-0FD2-4B70-8F34-900E6581B945

Q37014116-5C66CAB2-7151-4F4F-A44A-85797768E6B5

Q37014116-6383ABE4-9C58-4EC9-A61D-B57B236EB838

Q37014116-6C58EB00-9147-4947-99CD-39F416435889

P304

Q37014116-D9091A53-2DAD-4A7A-9851-DFC89C29CC24

P31

Q37014116-8AC68AD0-4A99-4543-A0C5-DB11D351662D

P356

Q37014116-B251D435-D517-4528-8368-2BF8AE50BDA3

P407

Q37014116-5B449E4A-577A-4DC1-B306-1A54A77298A4

P433

Q37014116-3469C99D-133A-4F05-B836-6966BE09DFF0

P478

Q37014116-8381A127-79A6-47F1-981B-ABBFC5E0D000

P577

Q37014116-08A0D0C4-224A-425C-8377-8C342B89FB9D

P698

Q37014116-1BA72C8B-C656-4501-984C-9ED94B1C531A

P921

Q37014116-22D36DCD-EEAC-4E0D-960D-52F14467D2A3

P932

Q37014116-B31954C7-87AA-43B4-A51D-B622691FD523

P356

QAI.0000000000000964

P1433

Journal of Acquired Immune Deficiency Syndromes

P1476

Brief Report: Relationship Amo ...... Treatment Interruption Trials.

@en

P2093

Daniel R Kuritzkes

http://www.w3.org/2001/XMLSchema#string

Evgenia Aga

http://www.w3.org/2001/XMLSchema#string

Graham C Treasure

http://www.w3.org/2001/XMLSchema#string

John W Mellors

http://www.w3.org/2001/XMLSchema#string

Jonathan Z Li

http://www.w3.org/2001/XMLSchema#string

Michael Para

http://www.w3.org/2001/XMLSchema#string

Rajesh T Gandhi

http://www.w3.org/2001/XMLSchema#string

Ronald J Bosch

http://www.w3.org/2001/XMLSchema#string

P2860

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection.

Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.

A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy

Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment

AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein.

HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy

Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection

Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases.

A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication.

P304

310-313

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAI.0000000000000964

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26910502

http://www.w3.org/2001/XMLSchema#string

P921

P932

4911279

http://www.w3.org/2001/XMLSchema#string